Chris is an Associate Director in Osborne Clarke's London corporate team. He specialises in UK and cross-border corporate transactional and advisory matters, including mergers and acquisitions, investments, joint ventures, reorganisations and general company law matters. 

Chris advises across a range of sectors and regions, with a particular focus on transactions in the Financial Services, Fintech, Workforce Solutions (staffing, recruitment, and consultancy), Technology and Retail & Consumer spaces.

Chris has broad experience acting for clients at all stages of the business life cycle, from owner-managed start-ups looking to scale to large listed companies focusing on strategic acquisitions and disposals.

Chris also has experience from the client perspective, having spent eight months on secondment to the Corporate and M&A legal team of one of the UK's largest retail and commercial banks. Prior to joining Osborne Clarke, he was the legal mentor to a Fintech start-up, working closely with the management team to focus on the key legal issues that the company faced.

"Whilst working with Chris on an extremely time bound M&A project, I found him to be pragmatic yet highly protective of our interests. The knowledge of his subject area and those other disciplines that touch the deal is vast."


Senior Legal Counsel, FTSE 100 client

Helping you succeed in tomorrow's world

"Navigating digital transformation continues to be a key objective at the heart of our clients' business strategies. I enjoy working with a range of clients on the digitalisation of their businesses, and I also represent our Financial Services team as the sector champion in Osborne Clarke's Digitalisation working group."

Computershare plc

Advised Computershare on the acquisition of the European public equity share plan business of Solium Capital UK (which trades as Shareworks by Morgan Stanley), such business managing plans with approximately 365,000 participants and $20bn in AUM.

Wilmington plc

Advised Wilmington on the disposal of mortality data business MiExact for c.£10m, and the disposal of its UK, Spanish and Swedish healthcare businesses for c.£26m.

Read more
Rethink Investments

Advised management on the MBO of recruitment solutions company Rethink.

Kester Capital

Advised Kester Capital on its acquisition of MAP Patient Access, a leading provider of market access consulting services to the pharmaceutical and biotech sectors.

Contact Chris
  • + 44 20 7105 7443
  • + 44 7570 367047
    • Add to contacts
    Share

    Insights

    Showing 1 - 2 of 2